ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

FDA's Science Board To Review Bisphenol A

June 16, 2008 | APPEARED IN VOLUME 86, ISSUE 24

At the request of FDA's chief scientist, Frank M. Torti, the agency's Science Board has established a new subcommittee to review the safety of the plastics chemical bisphenol A (BPA), a known endocrine disrupter. In April, because of an ongoing congressional investigation and a media firestorm focusing on the use of BPA in consumer products such as baby bottles and infant formula containers, FDA Commissioner Andrew C. von Eschenbach formed an agency-wide task force to review the safety of BPA in all FDA-regulated products. The new Science Board subcommittee will review a report this fall from that task force and hold a public meeting on the topic later this year, FDA Associate Commissioner for Science Norris E. Alderson said at a House Energy & Commerce subcommittee hearing on June 10. Alderson chairs FDA's BPA Task Force.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment